Pharmatek's Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
...results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot
rod Chemistry and Pharmatek Formulation Screening are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek Laboratories ma...
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
...ut Retinitis Pigmentosa
RP is a long lasting disease that slowly evolves towards irreversible
blindness. Classically in affected people, the retinal
rod photoreceptors
responsible for night vision and side vision slowly degenerate, first
leading to night blindness. As the disorder progresses, the cone
...
Avexa Reports Positive Phase IIb Result
...tional scientific conference.
Contact
Avexa Limited
Dr. Julian Chick, +61 (03) 9208 4300
Chief Executive Officer
or
Bourse Communications
Mr.
rod North, + 61 (03) 9510 8309 ...
Avexa's Apricitabine Clinical Trial Update
... Chick, +61 3 9208 4300
Chief Executive Officer
www.avexa.com.au
or
Bourse Communications
Mr rod North, + 61 (03) 9510-8309 ...